Article
Cascade genetic testing in hereditary cancer: exploring the boundaries of the Italian legal framework.
Familial cancer - 20 Nov 2024
Varesco Liliana, Di Tano Francesco, Monducci Juri, Sciallero Stefania, Turchetti Daniela, Bighin Claudia, Buzzatti Giulia, Giannubilo Irene, Trevisan Lucia, Battistuzzi Linda
Abstract excerpt
Despite its clinical value, cascade genetic testing (CGT) in hereditary cancer syndromes remains underutilized for a number of reasons, including ineffective family communication of genetic risk information. Therefore, alternative strategies are being explored to improve CGT uptake rates; one such strategy is direct contact with at-risk relatives by healthcare professionals with proband consent. It is unclear how...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
